Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by biotech1973on Mar 25, 2020 12:24pm
152 Views
Post# 30845869

Gunner and Edorse

Gunner and Edorse
Can you guys be realtistic for a moment. Enough of BS. The company was doing good even in 2018 ,FDA told the company to improve on check points but with Big Cash crunch, everything just went down the hill. Now the company is new with checkpoints to improve and theyve had meetings with FDA and even then FDA was ok with the improvements they made however with all restructing thing , it took us this long. NO CEO will join if the ship is sinking. We uave new team all together, and they even 2days ago assured that the timeline of 1Half is still the same with no change whatsoever. Now Edorse question on why dod they let go scientist. BECAUSE THIS COMPANY WILL BE SOLD POST APPROVAL AND COMMERCIALISATION. We all know about this. There is ZERO % Doubt in my mind. However Liminal at 8$ and 200 Milliin cap with PBI 4050 and Ryplazim, is a steal and at super Low valuation.. Coming to your point on Lawsuit, FORGET IT. Company is not stupid that they will do such big move without consulting lawyers..
<< Previous
Bullboard Posts
Next >>